- Wegovy-maker Novo Nordisk raises outlook as sales of its weight-loss drug soar CNBC
- Wegovy Pushes Novo Nordisk (NVO) Market Value Above Denmark GDP Bloomberg
- Novo Nordisk extends U.S. supply curbs on weight-loss drug Wegovy Reuters
- Novo Nordisk ADR Shows Market Leadership With Jump To 95 RS Rating Investor’s Business Daily
- Ozempic, Wegovy Maker Novo Nordisk Raises Outlook on Demand for Obesity Drugs Bloomberg
- View Full Coverage on Google News